✦ LIBER ✦

Double-blind comparison of etodolac sustained-release tablets and piroxicam capsules in patients with rheumatoid arthritis: An interim report

✍ Scribed by R.W. Jubb; P. Platt; T.R. Price

Book ID: 117090408
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 562 KB
Volume: 52
Category: Article
ISSN: 0011-393X
DOI: 10.1016/s0011-393x(05)80048-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Double-blind comparison of etodolac sust

Double-blind comparison of etodolac sustained-release tablets and diclofenac sustained-release tablets in patients with rheumatoid arthritis: An interim report

✍ F. Porzio; M. Schattenkirchner 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 524 KB

A double-blind comparison of parenteral

A double-blind comparison of parenteral methotrexate and parenteral gold in the treatment of early erosive rheumatoid arthritis: An interim report on 102 patients after 12 months

✍ R. Rau; G. Herborn; T. Karger; H. Menninger; D. Elhardt; J. Schmitt 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 822 KB

Brief Report: A phase IIa, randomized, d

Brief Report: A phase IIa, randomized, double-blind, placebo-controlled trial of apilimod mesylate, an interleukin-12/interleukin-23 inhibitor, in patients with rheumatoid arthritis

✍ Sarah Krausz; Maria J. H. Boumans; Danielle M. Gerlag; Joelle Lufkin; Arno W. R. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB

Rapid and sustained improvement in bone

Rapid and sustained improvement in bone and cartilage turnover markers with the anti–interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone

✍ Patrick Garnero; Elizabeth Thompson; Thasia Woodworth; Josef S. Smolen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB 👁 3 views

## Abstract ## Objective To investigate the effects of tocilizumab (TCZ) added to a stable dosage of methotrexate (MTX) on biochemical markers of bone and cartilage metabolism in patients in the multicenter double‐blind, placebo‐controlled OPTION (Tocilizumab Pivotal Trial in Methotrexate Inadequa